Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
September 30, 2026 0.04M
June 30, 2026 -0.0008M
March 31, 2026 0.2315M
December 31, 2025 0.0008M
September 30, 2025 -0.1372M
June 30, 2025 8.368M
March 31, 2025 2.831M
December 31, 2024 0.3239M
September 30, 2024 0.8382M
June 30, 2024 -0.0438M
March 31, 2024 0.0348M
December 31, 2023 4.618M
September 30, 2023 0.00
June 30, 2023 0.1297M
March 31, 2023 -0.0142M
December 31, 2022 5.108M
September 30, 2022 5.429M
June 30, 2022 4.988M
March 31, 2022 -0.0929M
December 31, 2021 -0.8382M
September 30, 2021 10.88M
June 30, 2021 0.0554M
March 31, 2021 5.997M
December 31, 2020 5.354M
September 30, 2020 -0.0646M
Date Value
June 30, 2020 -0.03M
March 31, 2020 0.0246M
December 31, 2019 -0.0246M
September 30, 2019 0.00
June 30, 2019 0.0495M
March 31, 2019 0.1457M
December 31, 2018 -0.0001M
September 30, 2018 0.0086M
June 30, 2018 10.64M
March 31, 2018 1.507M
December 31, 2017 6.278M
September 30, 2017 0.5412M
June 30, 2017 3.669M
March 31, 2017 2.287M
December 31, 2016 1.048M
September 30, 2016 0.2533M
June 30, 2016 0.1141M
March 31, 2016 0.0387M
December 31, 2015 0.1399M
September 30, 2015 0.0085M
June 30, 2015 0.849M
March 31, 2015 0.6842M
December 31, 2014 0.1154M
September 30, 2014 0.1066M
June 30, 2014 0.6323M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Liquidia Corp. -17.87M
Johnson & Johnson -8.533B
Eli Lilly & Co. -7.219B
Merck & Co., Inc. -2.432B
ANI Pharmaceuticals, Inc. -9.829M